Skip to content

MEDIFA

Active Risk: not assessed
Private limited companyfounded 2022active for 4 yearsKortrijksesteenweg 1202, 9051 Gent, BelgiumKBO/BCE: BE 0785.526.685
Summary

MEDIFA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €3.4m and a net result of €887,436. Equity is growing by about 26% per year across the filed financial years. Its solvency ranks better than 63% of 6,676 sector peers (NACE 64, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Articles of association

Other provisionsOther rules from the articles that fall under none of the themes above.
Other provision: “Verantwoordelijkheid bestuursorgaan bij inbreng in natura en uitgifte aandelen” (deed in Dutch)
Auditor report: “Verantwoordelijkheid bedrijfsrevisor bij inbreng in natura en uitgifte aandelen, artikel 5:121 en 5:133 Wetboek van vennootschappen en…” (deed in Dutch)

Read from the deeds: 2 provisions, deed of 27-10-2022